Cargando…
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
BACKGROUND: Osteosarcoma (OSA) is a highly metastatic pediatric bone tumor. Adjuvant chemotherapy and surgical resection represent standard treatments; however, the prognosis is still poor. Effective strategies are urgently needed. Chondroitin sulfate proteoglycan (CSPG)4 is a transmembrane proteogl...
Autores principales: | Riccardo, Federica, Tarone, Lidia, Iussich, Selina, Giacobino, Davide, Arigoni, Maddalena, Sammartano, Federica, Morello, Emanuela, Martano, Marina, Gattino, Francesca, Maria, Raffaella De, Ferrone, Soldano, Buracco, Paolo, Cavallo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557023/ https://www.ncbi.nlm.nih.gov/pubmed/31217827 http://dx.doi.org/10.1177/1758835919855491 |
Ejemplares similares
-
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022) -
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
por: Camerino, Mariateresa, et al.
Publicado: (2021) -
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
por: Giacobino, Davide, et al.
Publicado: (2021) -
CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017) -
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022)